Ho Carole

CIK 00017246055 companiesINDIANAPOLIS, IN

SEC Profile

Transactions

Companies

Filings

CIK

0001724605

Recent Transactions

50 trades

Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-08-13$14.64/sh−806→ 216,585 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-08-12$13.58/sh−2,937→ 217,391 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2025-08-05$0.68/sh+44,655→ 220,328 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-08-05−44,655→ 62,500 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-07-31+5,806→ 8,558 total
Award
Royalty Pharma plc$RPRX
Class A Ordinary Shares
2025-07-31+2,752→ 2,752 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2025-06-04+33,662→ 33,662 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-07$20.81/sh−2,907→ 175,673 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-06$20.22/sh−12,255→ 178,580 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2025-01-03+162,540→ 162,540 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2025-01-03+54,180→ 190,835 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Common Stock
2024-11-25$0.68/sh+17,845→ 136,655 total
Exercise/Conversion
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-11-25−17,845→ 107,155 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-21$24.96/sh−5,907→ 118,810 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-21$24.41/sh−14,098→ 124,717 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-20$23.79/sh−2,453→ 138,815 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-08-13$22.89/sh−2,337→ 141,268 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2024-06-05+23,114→ 23,114 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−24,222→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−39,515→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−19,619→ 0 total
Disposition to Issuer
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2024-04-05−78,407→ 0 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-02-14$17.79/sh−1,405→ 143,605 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-02-13$17.29/sh−2,784→ 145,010 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-10$19.02/sh−4,668→ 147,794 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-05$19.43/sh−9,972→ 198,777 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2024-01-03+53,720→ 162,434 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2024-01-03+161,160→ 161,160 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-23$23.22/sh−2,522→ 182,809 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-21$22.60/sh−2,478→ 185,331 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-14$23.79/sh−2,768→ 182,809 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-08-10$24.15/sh−2,857→ 185,577 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2023-06-06+16,532→ 16,532 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2023-05-10+78,407→ 78,407 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-15$29.40/sh−1,476→ 182,809 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-13$30.10/sh−2,548→ 184,285 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-10$29.80/sh−818→ 179,365 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-02-08$30.88/sh−1,521→ 180,183 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-09$28.48/sh−1,459→ 177,454 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-06$28.67/sh−1,451→ 178,913 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-05$28.44/sh−2,636→ 180,364 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-04$28.69/sh−2,913→ 175,500 total
Award
Denali Therapeutics Inc.$DNLI
Stock Option (right to buy)
2023-01-03+123,360→ 123,360 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2023-01-03+41,120→ 138,967 total
Award
Beam Therapeutics Inc.$BEAM
Stock Option (Right to Buy)
2022-09-01+10,391→ 10,391 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-08-23$31.98/sh−2,424→ 170,663 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-08-19$33.22/sh−2,576→ 173,087 total
Award
Denali Therapeutics Inc.$DNLI
Common Stock
2022-08-09+22,500→ 110,597 total
Award
NGM BIOPHARMACEUTICALS INC
Stock Option (Right to Buy)
2022-05-18+24,222→ 24,222 total
Sale
Denali Therapeutics Inc.$DNLI
Common Stock
2022-02-11$34.71/sh−2,918→ 170,663 total

Companies

Recent Filings

Address

LILLY CORPORATE CENTER

INDIANAPOLIS, IN, 46285

View on SEC.gov